Bonatra, a health start-up has acquired women’s health and wellness company MyAva. Through this acquisition, Bonatra aims to expand its healthcare programs and become a one-stop platform for the management of chronic health conditions.
MyAva is a fem-tech start-up that empowers women to manage chronic health conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, insulin resistance and more. The company was founded in 2019 by Evelyn Immanuel.
Bonatra is a doctor-led IoMT (Internet of Medical Things) start-up focused on treating and managing chronic diseases such as diabetes, hypertension, fatty liver, PCOD, obesity etc.. Bonatra uses personalised treatment, which is arrived at after analysing multiple data points and health parameters using various easy-to-use IoMT devices.
Founded in April 2022 by Rahul Kishore Singh, Manjari Chandra, Ramanpreet Singh and Amit Acharya, Bonatra integrates clinical acumen with technology to achieve holistic health. The solutions at Bonatra include personalised, targeted lifestyle, nutritional and fitness interventions to balance hormones and supplementing it with other functional methods of gut reset, correcting gut dysbiosis(imbalance in gut bacteria) and harnessing natural detox procedures to reduce heavy metal toxicity in the body.
“We are thrilled to welcome MyAva to join the Bonatra family. Acquiring MyAva enables us to expand our reach and deepen our expertise in women’s health, specifically for conditions like PCOS. We have been closely working with and interacting with the MyAva team and we believe that this will be a good strategic fit for Bonatra. Our mission is to empower people to take proactive measures to prevent, manage, and reverse chronic health conditions. This move will further strengthen our expertise in holistic healthcare solutions,” said Rahul Kishore Singh, CEO (chief executive officer) and co-founder, Bonatra.
"MyAva is elated to join Bonatra and further the vision of making chronic care management accessible to all women. We believe this further strengthens our combined commitment towards making femtech more inclusive and integrated,” added Evelyn Immanuel, founder and CEO, MyAva.
“I am confident that Bonatra’s acquisition of MyAva is a move in the right direction and it will further enhance the company’s offering. Bonatra's expansion into women's health and wellness through the acquisition of MyAva will solidify its position as a leading player in the healthcare industry. The combination of Bonatra's personalized treatment approach and MyAva's trusted programs and plans for managing chronic health conditions in women addresses a large unmet need in the market. I look forward to seeing the continued growth and success of Bonatra with this new addition to their platform. Wishing both the teams success in their joint endeavour and scaling new peaks," observed Yagnesh Sanghrajka, founder and CFO (chief financial officer), 100X. VC.
Over the next six months, Bonatra has plans to introduce newer IoMT devices including a smart ring in the Indian market to further strengthen its solutions which are a convergence of medical science, data science and technology.
Recently, the company raised 5.5 crores in a pre-seed round led by ITI Growth Opportunities Fund with participation from marquee angel investors like Jitendra Jagadev, Founder, Nestaway and Helloworld, and Rajesh Yabaji, Founder, Blackbuck.
